Portfolio company
XPAMAC
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
XPAMAC develops mammalian cell lines for therapeutic protein production, serving biopharmaceutical companies and contract development and manufacturing organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellagenics
This biotechnology firm develops technology to enhance therapeutic antibody and protein production in mammalian cell lines for biopharmaceutical manufacturers.
BioCeros
This company provides cell line development services for monoclonal antibody production to biotechnology firms, pharmaceutical companies and academic institutions.
CEVEC Pharmaceuticals GmbH
The company develops human cell line expression systems and viral vector manufacturing platforms for pharmaceutical and biotechnology organisations producing biotherapeutics.
PharmaCell
The company provides contract manufacturing and development services for cell and gene therapy products to pharmaceutical and biotechnology clients.
NorthX Biologics
This company provides complex biologics manufacturing services, including recombinant proteins and cell therapies, to a global customer base of biopharmaceutical and biotech companies.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
CEVEC
The company produces human cell-based expression systems and viral vector manufacturing technologies for biopharmaceutical firms and biotechnology organisations developing therapeutic proteins and gene therapies.
Augment Biologics
This company develops a glycoengineering platform for designing therapeutic proteins with specific sugar patterns for pharmaceutical manufacturers and biotechnology research teams.
